Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, Bonnefoi H, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 2007;18:1927–34. https://doi.org/10.1093/annonc/mdm201.

Article  CAS  PubMed  Google Scholar 

Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, et al. Breast conservation after neoadjuvant chemotherapy. Cancer. 2005;103:689–95. https://doi.org/10.1002/cncr.20815.

Article  PubMed  Google Scholar 

Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008;26:778–85. https://doi.org/10.1200/jco.2007.15.0235.

Article  PubMed  Google Scholar 

Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672–85. https://doi.org/10.1200/jco.1998.16.8.2672.

Article  CAS  PubMed  Google Scholar 

Marinovich ML, Houssami N, Macaskill P, Sardanelli F, Irwig L, Mamounas EP, et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst. 2013;105:321–33. https://doi.org/10.1093/jnci/djs528.

Article  CAS  PubMed  Google Scholar 

Lobbes MBI, Prevos R, Smidt M, Tjan-Heijnen VCG, van Goethem M, Schipper R, et al. The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review. Insights imaging. 2013;4:163–75. https://doi.org/10.1007/s13244-013-0219-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

An YY, Kim SH, Kang BJ. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor. World J Surg Oncol. 2017;15:198. https://doi.org/10.1186/s12957-017-1263-8.

Article  PubMed  PubMed Central  Google Scholar 

Feliciano Y, Mamtani A, Morrow M, Stempel MM, Patil S, Jochelson MS. Do calcifications seen on mammography after neoadjuvant chemotherapy for breast cancer always need to be excised? Ann Surg Oncol. 2017;24:1492–8. https://doi.org/10.1245/s10434-016-5741-y.

Article  PubMed  Google Scholar 

Yim H, Ha T, Kang DK, Park SY, Jung Y, Kim TH. Change in microcalcifications on mammography after neoadjuvant chemotherapy in breast cancer patients: correlation with tumor response grade and comparison with lesion extent. Acta Radiol. 2019;60:131–9. https://doi.org/10.1177/0284185118776491.

Article  PubMed  Google Scholar 

Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 2015;22:1111–7. https://doi.org/10.1245/s10434-014-4113-8.

Article  PubMed  Google Scholar 

Weiss A, Lee KC, Romero Y, Ward E, Kim Y, Ojeda-Fournier H, et al. Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy. Ann Surg Oncol. 2014;21:3310–6. https://doi.org/10.1245/s10434-014-3914-0.

Article  PubMed  Google Scholar 

Kim YS, Chang JM, Moon HG, Lee J, Shin SU, Moon WK. Residual mammographic microcalcifications and enhancing lesions on MRI after neoadjuvant systemic chemotherapy for locally advanced breast cancer: correlation with histopathologic residual tumor size. Ann Surg Oncol. 2016;23:1135–42. https://doi.org/10.1245/s10434-015-4993-2.

Article  PubMed  Google Scholar 

Moskovic EC, Mansi JL, King DM, Murch CR, Smith IE. Mammography in the assessment of response to medical treatment of large primary breast cancer. Clin Radiol. 1993;47:339–44. https://doi.org/10.1016/S0009-9260(05)81451-5.

Article  CAS  PubMed  Google Scholar 

Gwark S, Kim HJ, Kim J, Chung IY, Kim HJ, Ko BS, et al. Survival after breast-conserving surgery compared with that after mastectomy in breast cancer patients receiving neoadjuvant chemotherapy. Ann Surg Oncol. 2023;30:2845–53. https://doi.org/10.1245/s10434-022-12993-0.

Article  PubMed  Google Scholar 

Tasoulis M-K, Lee H-B, Kuerer HM. Omission of breast surgery in exceptional responders. Clin Breast Cancer. 2024. https://doi.org/10.1016/j.clbc.2024.01.021.

Article  PubMed  Google Scholar 

D’Orsi CSE, Mendelson EB, Morris EA. ACR BI-RADS atlas: breast imaging reporting and data system. 5th ed. Reston: American College of Radiology; 2013.

Google Scholar 

Nishino M, Jagannathan JP, Ramaiya NH, Van den Abbeele AD. Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know. AJR Am J Roentgenol. 2010;195:281–9. https://doi.org/10.2214/ajr.09.4110.

Article  PubMed  Google Scholar 

Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 2010;28:1684–91. https://doi.org/10.1200/jco.2009.24.9284.

Article  PubMed  Google Scholar 

Bustreo S, Osella-Abate S, Cassoni P, Donadio M, Airoldi M, Pedani F, et al. Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up. Breast Cancer Res Treat. 2016;157:363–71. https://doi.org/10.1007/s10549-016-3817-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and regression trees. Taylor & Francis; 1984.

Google Scholar 

Choi WJ, Kim HH, Cha JH, Shin HJ, Chae EY, Yoon GY. Complete response on MR imaging after neoadjuvant chemotherapy in breast cancer patients: Factors of radiologic-pathologic discordance. Eur J Radiol. 2019;118:114–21. https://doi.org/10.1016/j.ejrad.2019.06.017.

Article  PubMed  Google Scholar 

Kwon MR, Chu J, Kook SH, Kim EY. Factors associated with radiologic-pathologic discordance in magnetic resonance imaging after neoadjuvant chemotherapy for breast cancer. Clin Imaging. 2022;89:1–9. https://doi.org/10.1016/j.clinimag.2022.05.002.

Article  PubMed  Google Scholar 

Kim J, Han BK, Ko EY, Ko ES, Choi JS, Park KW. Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes. Eur Radiol. 2022;32:4056–66. https://doi.org/10.1007/s00330-021-08461-0.

Article  CAS  PubMed  Google Scholar 

Li JJ, Chen C, Gu Y, Di G, Wu J, Liu G, et al. The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation. PLoS ONE. 2014;9:e88853. https://doi.org/10.1371/journal.pone.0088853.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mazari FAK, Sharma N, Dodwell D, Horgan K. Human epidermal growth factor 2-positive breast cancer with mammographic microcalcification: relationship to pathologic complete response after neoadjuvant chemotherapy. Radiology. 2018;288:366–74. https://doi.org/10.1148/radiol.2018170960.

Article  PubMed  Google Scholar 

Kim EY, Do SI, Yun JS, Park YL, Park CH, Moon JH, et al. Preoperative evaluation of mammographic microcalcifications after neoadjuvant chemotherapy for breast cancer. Clin Radiol. 2020;75:641.e19-.27. https://doi.org/10.1016/j.crad.2020.03.024.

Article  CAS  PubMed  Google Scholar